News | November 10, 2021
Strides Pharma Science incurs Rs 162.55 cr. loss in Q2FY22
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The drug helps in managing cholesterol
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Subscribe To Our Newsletter & Stay Updated
